Genetics
Our genetics research focuses on understanding the fundamental mechanisms of genetic diseases and developing innovative therapies to treat them. We aim to unlock the secrets of the human genome and translate our findings into clinical applications that improve patient outcomes.
Past Projects
- Project Genome Mapping: This project involved mapping the entire human genome to identify genetic markers associated with various diseases. Our findings have led to the development of targeted therapies for genetic disorders.
- Gene Editing for Cystic Fibrosis: Utilizing CRISPR technology, we successfully edited the faulty gene responsible for cystic fibrosis in cell models, paving the way for potential gene therapy treatments.
- Epigenetic Modifications in Cancer: Investigating how epigenetic changes influence cancer progression, we discovered novel biomarkers for early cancer detection and new targets for treatment.
Current Projects
- Precision Medicine Initiative: This project aims to develop personalized treatment plans based on individual genetic profiles, enhancing the effectiveness of therapies and minimizing side effects.
- Genetic Basis of Rare Diseases: We are exploring the genetic underpinnings of rare diseases to identify potential therapeutic targets and develop innovative treatments for these conditions.
Oncology
Our oncology research is dedicated to understanding the complexities of cancer biology and developing novel therapies to combat various forms of cancer. We focus on translating our discoveries into clinical applications that improve survival rates and quality of life for cancer patients.
Past Projects
- Targeted Therapy for Breast Cancer: We developed a targeted therapy that selectively kills cancer cells while sparing healthy tissue, significantly improving treatment outcomes for breast cancer patients.
- Immunotherapy for Melanoma: Our research led to the development of an immunotherapy treatment that harnesses the body's immune system to fight melanoma, resulting in increased survival rates.
- Early Detection of Lung Cancer: We identified biomarkers for the early detection of lung cancer, allowing for earlier intervention and improved patient prognosis.
Current Projects
- Combination Therapy for Colorectal Cancer: This project explores the synergistic effects of combining different therapeutic agents to enhance the efficacy of colorectal cancer treatments.
- Nanotechnology in Cancer Treatment: We are investigating the use of nanotechnology to deliver targeted therapies directly to cancer cells, minimizing side effects and improving treatment outcomes.
Neurology
Our neurology research aims to unravel the complexities of the nervous system and develop therapies for neurological disorders. We focus on understanding the molecular and cellular mechanisms underlying these conditions to translate our findings into effective treatments.
Past Projects
- Stem Cell Therapy for Spinal Cord Injury: We successfully used stem cell therapy to promote the regeneration of damaged spinal cord tissue, offering hope for patients with spinal cord injuries.
- Neurodegenerative Disease Biomarkers: Identifying biomarkers for diseases like Alzheimer's and Parkinson's has allowed for earlier diagnosis and intervention, improving patient outcomes.
- Brain-Computer Interface Development: Our research in brain-computer interfaces has led to the development of devices that enable communication and control for patients with severe neurological impairments.
Current Projects
- Gene Therapy for ALS: This project aims to develop gene therapy treatments for Amyotrophic Lateral Sclerosis (ALS) by targeting the genetic mutations responsible for the disease.
- Neuroinflammation in Multiple Sclerosis: We are investigating the role of neuroinflammation in multiple sclerosis to identify new therapeutic targets and develop more effective treatments.